Edited by Lam Su Datt, Yam Wai Keat, M. Firdaus Raih, and Phoebe Chen
On the challenges of predicting treatment response in Hodgkin’s Lymphoma using transcriptomic data
Despite the advancements in multiagent chemotherapy in the past years, up to 10% of Hodgkin’s Lymphoma (HL) cases are refractory to treatment and, after remission, patients experience an elevated risk of death...